immune system
• increased CD3+ cell number in liver when subjected to 70% liver ischemia reperfusion injury (IRI)
|
• increased CD16+ cell number in liver when subjected to 70% liver ischemia reperfusion injury (IRI)
|
• increased F4/80+ cell number in liver when subjected to 70% liver ischemia reperfusion injury (IRI)
|
homeostasis/metabolism
N |
• no change in glucose tolerance, insulin resistance, hyperglycemia, body weight increase, fasting blood glucose levels, steatosis and serum lipid levels compared to wild-type when fed high-fat diet (HFD), with or without doxepin treatment
|
• when subjected to 70% liver ischemia reperfusion injury (IRI)
|
• when subjected to 70% liver ischemia reperfusion injury (IRI)
|
• increased GDH activity when subjected to 70% liver ischemia reperfusion injury (IRI)
|
• when subjected to 70% liver ischemia reperfusion injury (IRI)
|
• increased NO level in liver when subjected to 70% liver ischemia reperfusion injury (IRI)
|
hematopoietic system
• increased CD3+ cell number in liver when subjected to 70% liver ischemia reperfusion injury (IRI)
|
• increased CD16+ cell number in liver when subjected to 70% liver ischemia reperfusion injury (IRI)
|
• increased F4/80+ cell number in liver when subjected to 70% liver ischemia reperfusion injury (IRI)
|
mortality/aging
• increased liver damage when subjected to 70% liver ischemia reperfusion injury (IRI)
• reduced total anti-oxidative capacity (T-AOC) when subjected to liver IRI
• increased methane dicarboxylic aldehyde (MDA) levels and myeloperoxidase (MPO) activity when subjected to liver IRI
• reduced cellular ATP levels in liver when subjected to liver IRI
|